Though the Ebola virus scare has calmed down quite a bit in the U.S., it still remains a concern in West Africa. Novavax is a small-cap, speculative vaccine play that is in the epicenter of this as it just announced a phase one clinical trial for an Ebola vaccine.
The connection to Ebola has caused the company to skyrocket 39 percent in the past month. Will it continue to fly high?
To find out, Cramer sat down with the CEO of Novavax, Stanley Erck.
"What you need for a vaccine like this is what our platform does, which allows us to make a vaccine that you can make large quantities of millions of doses a month that is deliverable at refrigerated temperatures instead of -70 degrees which is the problem with the current vaccines," said Erck.
Another stock sprouting monstrous growth in the restaurant technology space is the privately held company Ziosk.
This company is on the cutting edge of technology to change the dining experience by providing restaurants with tabletop ordering tablets. These snazzy tablets allow customers to order food, pay the bill, surf the Internet and play games.
Ziosk already has Chili's under its belt, and its tablets now dot every location. On Friday, it also announced a deal to add tablets to 500 Red Robin Gourmet Burger locations. Could this be just the beginning?
Cramer spoke with Ziosk CEO Austen Mulinder to find out.
"The top priority is guest experience. They want to give the guest some control, the opportunity for entertainment and in return they get to know that guest better and if they serve them better they will come back more often," said Mulinder.
In the Lightning Round, Cramer gave his take on a few caller favorite stocks:
Spectra Energy Corp: "I like this stock. The utilities have been crushed here, but it's got a 4 percent yield. Remember, interest rates seem to be going higher and you're not going to make a lot of money in this name but it's one of the higher quality ones."
Becton, Dickinson & Co: "I love that acquisition, it's going to give them the growth they need."
Read MoreLightning Round: A great quarter and a great stock